<DOC>
	<DOC>NCT01400854</DOC>
	<brief_summary>Aim of this non-interventional study is to investigate the tolerability of Effentora® in cancer pain patients with breakthrough pain under real-life conditions in clinical practice.</brief_summary>
	<brief_title>Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability</brief_title>
	<detailed_description>In addition to the effectiveness of Effentora® therapy, safety, general feasibility and the impact of therapy on the patients' quality of life are of interest.</detailed_description>
	<criteria>decision to start treatment with Effentora prescription in accordance with Summary of Product Characteristics (SmPC) personally signed and dated Informed Consent document any subject considered unsuitable according to SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>breakthrough cancer pain</keyword>
</DOC>